Skip to main content
Erschienen in: Journal of Neurology 7/2011

01.07.2011 | Original Communication

Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I

verfasst von: A. Palmieri, R. Manara, L. Bello, G. Mento, L. Lazzarini, C. Borsato, L. Bortolussi, C. Angelini, E. Pegoraro

Erschienen in: Journal of Neurology | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Limb-girdle muscular dystrophy 2I (LGMD2I) is a neuromuscular disorder with a heterogeneous phenotype. It is caused by mutations in the Fukutin Related Protein (FKRP) gene, which is ubiquitously expressed in human tissues. FKRP functions in CNS are largely unknown. To investigate possible cognitive impairment in LGMD2I and to describe brain MRI features. Ten LGMD2I patients (four males and six females, mean age 44 years, age range 19–69 years) were assessed with an extensive neuropsychological battery, psychopathological tests and neuromuscular specific quality-of-life questionnaire. Adults were compared with ten matched healthy controls. All patients underwent complete neurological examination, and nine underwent brain MRI scanning. Patients showed a fairly specific cognitive profile with mild impairment in executive functions and visuo-spatial planning without substantial impairment in global and logic IQ. MRI findings were heterogeneous: four patients showed non-specific white matter abnormalities; two patients showed moderate ventriculomegaly; three patients showed mild enlargement of subarachnoid spaces, without a specific pattern. Cerebellar atrophy was marked in one patient. Abnormal glycosylation of α-dystroglycan in LGMD2I may interfere with brain development and cognitive performances involving the frontal and posterior parietal regions, but does not result in specific brain MRI abnormalities.
Literatur
1.
Zurück zum Zitat Clement E, Mercuri E, Godfrey C, Smith J, Robb S, Kinali M, Straub V, Bushby K, Manzur A, Talim B, Cowan F, Quinlivan R, Klein A, Longman C, McWilliam R, Topaloglu H, Mein R, Abbs S, North K, Barkovich AJ, Rutherford M, Muntoni F (2008) Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 64:573–582PubMedCrossRef Clement E, Mercuri E, Godfrey C, Smith J, Robb S, Kinali M, Straub V, Bushby K, Manzur A, Talim B, Cowan F, Quinlivan R, Klein A, Longman C, McWilliam R, Topaloglu H, Mein R, Abbs S, North K, Barkovich AJ, Rutherford M, Muntoni F (2008) Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 64:573–582PubMedCrossRef
2.
Zurück zum Zitat Topaloglu H, Brockington M, Yuva Y, Talim B, Haliloglu G, Blake D, Torelli S, Brown SC, Muntoni F (2003) FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology 60:988–992PubMed Topaloglu H, Brockington M, Yuva Y, Talim B, Haliloglu G, Blake D, Torelli S, Brown SC, Muntoni F (2003) FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology 60:988–992PubMed
3.
Zurück zum Zitat Louhichi N, Triki C, Quijano-Roy S, Richard P, Makri S, Méziou M, Estournet B, Mrad S, Romero NB, Ayadi H, Guicheney P, Fakhfakh F (2004) New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities: identification of a founder mutation in Tunisian families. Neurogenetics 5:27–34PubMedCrossRef Louhichi N, Triki C, Quijano-Roy S, Richard P, Makri S, Méziou M, Estournet B, Mrad S, Romero NB, Ayadi H, Guicheney P, Fakhfakh F (2004) New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities: identification of a founder mutation in Tunisian families. Neurogenetics 5:27–34PubMedCrossRef
4.
Zurück zum Zitat Mercuri E, Topaloglu H, Brockington M, Berardinelli A, Pichiecchio A, Santorelli F, Rutherford M, Talim B, Ricci E, Voit T, Muntoni F (2006) Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. Arch Neurol 63:251–257PubMedCrossRef Mercuri E, Topaloglu H, Brockington M, Berardinelli A, Pichiecchio A, Santorelli F, Rutherford M, Talim B, Ricci E, Voit T, Muntoni F (2006) Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. Arch Neurol 63:251–257PubMedCrossRef
5.
Zurück zum Zitat Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, Birchall D, Brockington M, Buddles M, Busby M, Muntoni F, Wills A, Bushby K (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60:1246–1251PubMed Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, Birchall D, Brockington M, Buddles M, Busby M, Muntoni F, Wills A, Bushby K (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60:1246–1251PubMed
6.
Zurück zum Zitat Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A, Siciliano G, Angelini C, Pegoraro E (2005) Clinical and molecular characterization of patients with Limb-Girdle Muscular Dystrophy Type 2I. Arch Neurol 62:1894–1899PubMedCrossRef Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A, Siciliano G, Angelini C, Pegoraro E (2005) Clinical and molecular characterization of patients with Limb-Girdle Muscular Dystrophy Type 2I. Arch Neurol 62:1894–1899PubMedCrossRef
7.
Zurück zum Zitat Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, Anderson LV, Bashir R, Burgunder JM, Fallet S, Romero N, Fardeau M, Straub V, Storey G, Pollitt C, Richard I, Sewry CA, Bushby K, Voit T, Blake DJ, Muntoni F (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10:2851–2859PubMedCrossRef Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, Anderson LV, Bashir R, Burgunder JM, Fallet S, Romero N, Fardeau M, Straub V, Storey G, Pollitt C, Richard I, Sewry CA, Bushby K, Voit T, Blake DJ, Muntoni F (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10:2851–2859PubMedCrossRef
8.
Zurück zum Zitat Michele DE, Campbell KP (2003) Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem 278:15457–15460PubMedCrossRef Michele DE, Campbell KP (2003) Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem 278:15457–15460PubMedCrossRef
9.
Zurück zum Zitat Longman C, Brockington M, Torelli Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F (2003) Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 12:2853–2861PubMedCrossRef Longman C, Brockington M, Torelli Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F (2003) Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 12:2853–2861PubMedCrossRef
10.
Zurück zum Zitat Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP (2002) Delation of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418:417–422PubMedCrossRef Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP (2002) Delation of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418:417–422PubMedCrossRef
11.
Zurück zum Zitat Quijano-Roy S, Martì-Carrera I, Makri S, Mayer M, Maugenre S, Richard P, Berard C, Viollet L, Leheup B, Guicheney P, Pinard JM, Estournet B, Carlier RY (2006) Brain MRI abnormalities in muscular dystrophy due to FKRP mutations. Brain Dev 28:232–242PubMedCrossRef Quijano-Roy S, Martì-Carrera I, Makri S, Mayer M, Maugenre S, Richard P, Berard C, Viollet L, Leheup B, Guicheney P, Pinard JM, Estournet B, Carlier RY (2006) Brain MRI abnormalities in muscular dystrophy due to FKRP mutations. Brain Dev 28:232–242PubMedCrossRef
12.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An Inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An Inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed
13.
Zurück zum Zitat Spielbergher CD, Gursuch RL, Lushene RE (1989) State-Trait Anxiety Inventory-Y Form. Italian edition by Pedrabissi L, Santinello M. O.S. Firenze, Firenze, Italy Spielbergher CD, Gursuch RL, Lushene RE (1989) State-Trait Anxiety Inventory-Y Form. Italian edition by Pedrabissi L, Santinello M. O.S. Firenze, Firenze, Italy
14.
Zurück zum Zitat Fanin M, Angelini C (2002) Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol 28:461–470PubMedCrossRef Fanin M, Angelini C (2002) Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol 28:461–470PubMedCrossRef
15.
Zurück zum Zitat Sartori G, Colombo L, Vallar G, Rusconi ML, Pinarello A (1997) T.I.B. Test di intelligenza breve per la valutazione del quoziente intellettivo attuale e pre-morboso. Giornale dell’ordine Nazionale Degli Psicologi 1:2–24 Sartori G, Colombo L, Vallar G, Rusconi ML, Pinarello A (1997) T.I.B. Test di intelligenza breve per la valutazione del quoziente intellettivo attuale e pre-morboso. Giornale dell’ordine Nazionale Degli Psicologi 1:2–24
16.
Zurück zum Zitat Nelson HE, O’Connel A (1978) Dementia: the examination of pre-morbid intelligence levels using the new adult reading test. Cortex 14:234–244PubMed Nelson HE, O’Connel A (1978) Dementia: the examination of pre-morbid intelligence levels using the new adult reading test. Cortex 14:234–244PubMed
17.
Zurück zum Zitat Sánchez-Cubillo I, Periáñez JA, Adrover-Roig D, Rodríguez-Sánchez JM, Ríos-Lago M, Tirapu J, Barceló F (2009) Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Inter Neuropsychol Soc 15:438–450CrossRef Sánchez-Cubillo I, Periáñez JA, Adrover-Roig D, Rodríguez-Sánchez JM, Ríos-Lago M, Tirapu J, Barceló F (2009) Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Inter Neuropsychol Soc 15:438–450CrossRef
18.
Zurück zum Zitat Bianchi A, Dai Prà M (2008) Twenty years after Spinnler and Tognoni: new instruments in the Italian neuropsychologist’s toolbox. Neurol Sci 29:209–217PubMedCrossRef Bianchi A, Dai Prà M (2008) Twenty years after Spinnler and Tognoni: new instruments in the Italian neuropsychologist’s toolbox. Neurol Sci 29:209–217PubMedCrossRef
19.
Zurück zum Zitat Sansone VA, Panzeri M, Montanari M, Apolone G, Gandossini S, Rose MR, Politano L, Solimene C, Siciliano G, Volpi L, Angelini C, Palmieri A, Toscano A, Musumeci O, Mongini T, Vercelli L, Massa R, Panico MB, Grandi M, Meola G (2010) Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases. Eur J Neurol 17:1178–1187PubMedCrossRef Sansone VA, Panzeri M, Montanari M, Apolone G, Gandossini S, Rose MR, Politano L, Solimene C, Siciliano G, Volpi L, Angelini C, Palmieri A, Toscano A, Musumeci O, Mongini T, Vercelli L, Massa R, Panico MB, Grandi M, Meola G (2010) Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases. Eur J Neurol 17:1178–1187PubMedCrossRef
20.
Zurück zum Zitat Hirashima Y, Shindo K, Endo S (1983) Measurement of the area of the anterior horn of the right lateral ventricle for the diagnosis of brain atrophy by CT. Correlation with several ventricular indices. Neuroradiology 25:23–27PubMedCrossRef Hirashima Y, Shindo K, Endo S (1983) Measurement of the area of the anterior horn of the right lateral ventricle for the diagnosis of brain atrophy by CT. Correlation with several ventricular indices. Neuroradiology 25:23–27PubMedCrossRef
21.
Zurück zum Zitat Monchi O, Petrides M, Petre V, Worsley K, Dagher A (2001) Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 21:7733–7741PubMed Monchi O, Petrides M, Petre V, Worsley K, Dagher A (2001) Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 21:7733–7741PubMed
22.
Zurück zum Zitat Zakzanis KK, Mraz R, Graham SJ (2005) An fMRI study of the Trail Making Test. Neuropsychologia 43:1878–1886PubMedCrossRef Zakzanis KK, Mraz R, Graham SJ (2005) An fMRI study of the Trail Making Test. Neuropsychologia 43:1878–1886PubMedCrossRef
23.
Zurück zum Zitat Lie CH, Specht K, Marshall JC, Fink GR (2006) Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test. Neuroimage 30:1038–1049PubMedCrossRef Lie CH, Specht K, Marshall JC, Fink GR (2006) Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test. Neuroimage 30:1038–1049PubMedCrossRef
24.
Zurück zum Zitat Gonzalez-Hernandez JA, Pita-Alcorta C, Cedeno I, Bosch-Bayard J, Galán-Garcia L, Scherbaum WA, Figueredo-Rodriguez P (2002) Wisconsin Card Sorting Test synchronizes the prefrontal, temporal and posterior association cortex in different frequency ranges and extensions. Hum Brain Map 17:37–47CrossRef Gonzalez-Hernandez JA, Pita-Alcorta C, Cedeno I, Bosch-Bayard J, Galán-Garcia L, Scherbaum WA, Figueredo-Rodriguez P (2002) Wisconsin Card Sorting Test synchronizes the prefrontal, temporal and posterior association cortex in different frequency ranges and extensions. Hum Brain Map 17:37–47CrossRef
25.
Zurück zum Zitat Grossi D, Trojano L (2001) Constructional and visuospatial disorders In: Boller F, Grafman J (Eds) Handbook of neuropsychology. Elsevier, Amsterdam, pp 99–120 Grossi D, Trojano L (2001) Constructional and visuospatial disorders In: Boller F, Grafman J (Eds) Handbook of neuropsychology. Elsevier, Amsterdam, pp 99–120
26.
Zurück zum Zitat Freeman RQ, Giovannetti T, Lamar M, Cloud BS, Stern RA, Kaplan E, Libon DJ (2000) Visuoconstructional problems in dementia: contribution of executive systems functions. Neuropsychology 14:415–426PubMedCrossRef Freeman RQ, Giovannetti T, Lamar M, Cloud BS, Stern RA, Kaplan E, Libon DJ (2000) Visuoconstructional problems in dementia: contribution of executive systems functions. Neuropsychology 14:415–426PubMedCrossRef
27.
Zurück zum Zitat Olesen PJ, Nagy Z, Westerberg H, Klingberg T (2003) Combined analysis of DTI and fMRI data reveals a joint maturation of white and grey matter in a fronto-parietal network. Brain Res Cogn Brain Res 18:48–57PubMedCrossRef Olesen PJ, Nagy Z, Westerberg H, Klingberg T (2003) Combined analysis of DTI and fMRI data reveals a joint maturation of white and grey matter in a fronto-parietal network. Brain Res Cogn Brain Res 18:48–57PubMedCrossRef
Metadaten
Titel
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I
verfasst von
A. Palmieri
R. Manara
L. Bello
G. Mento
L. Lazzarini
C. Borsato
L. Bortolussi
C. Angelini
E. Pegoraro
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 7/2011
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-5930-3

Weitere Artikel der Ausgabe 7/2011

Journal of Neurology 7/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.